Stanford Bio-X affiliated faculty members and fellows are generating scientific advances that expand our understanding of how the body works and will ultimately improve human health. These news stories and press releases describe some of those breakthroughs.
May 24, 2017 - Stanford Medicine News Center
Research from Bio-X affiliates Euan Ashley and Trevor Hastie and Bio-X Fellow Anna Shcherbina into the accuracy of 7 wristband activity monitors showed that 6 out of 7 measured heart rate within 5%, but none measured energy expenditure well.
May 22, 2017 - Stanford Engineering
Bio-X affiliate Chris Manning discusses the evolution of computational linguistics and where it's headed next. He was recently named the Thomas M. Siebel Professor in Machine Learning.
May 22, 2017 - Stanford Medicine Scope
Stanford cardiologist Tim Assimes and a consortium of scientists including Bio-X affiliate Tom Quertermous pinpointed 15 newly identified genomic regions associated with heart disease.
May 19, 2017 - Stanford Medicine News Center
As research from Bio-X affiliate Alan Schatzberg and others shows that the hallucinogen is a potentially powerful treatment for intractable mental disorders, and academics continue to debate its safety, private clinics offer the drug to patients now.
May 18, 2017 - Stanford Medicine Scope
Bio-X affiliate Peter Parham examined a particular version of a gene which encodes for an important cell-surface protein that’s a key player in our immune response.
May 18, 2017 - Stanford News
Bio-X affiliate Robert Sinclair finds that nanoscale stretching or compressing boosts the performance of ceria, a material used in catalytic converters and clean-energy tech.
May 9, 2017 - Stanford News
Quantum computing could outsmart current computing if scientists figure out how to make it practical. Bio-X affiliates Jelena Vuckovic, Nicholas Melosh, and Steve Chu are investigating new materials that could become the basis for such an advance.
May 8, 2017 - Stanford News
With the publication of his latest book, Bio-X affiliate Robert Sapolsky tackles the best and worst of human behavior and the nature of justice in the absence of free will.
May 8, 2017 - Stanford Medicine News Center
Stanford scientists including Bio-X affiliate Dennis Wall have launched a crowdsourcing project to pinpoint areas across the globe that have few autism experts, leading to delayed care for kids who live there, and to find ways to fill them.
May 4, 2017 - Stanford Medicine Scope
Bio-X affiliates Philip Beachy and Michael Clarke have discovered a new way that the GLI2 gene impacts breast development: they found that GLI2 activity helps control mammary stem cells in mice.
May 3, 2017 - Stanford Medicine News Center
Liver disease expert, leading anti-hepatitis campaigner, and Bio-X affiliate Samuel So recently discussed what it will take to rub out viral hepatitis, which causes more than 20,000 U.S. deaths annually.
April 26, 2017 - Stanford Medicine News Center
Bio-X affiliates Sergiu Pasca, John Huguenard, Joachim Hallmayer, Jonathan Bernstein, and Lars Steinmetz fused two stem-cell-derived neural spheroids and watched as the two sets of neurons migrated and connected.
April 24, 2017 - Stanford Medicine Scope
New research from Bio-X affiliates Michelle Monje and Joanna Wysocka suggests two potential drug targets for the pediatric brain tumor diffuse intrinsic pontine glioma.
April 24, 2017 - Stanford News
A new four-step “framework” from researchers including Bio-X affiliate Bala Rajaratnam aims to test the contribution of climate change to record-setting extreme weather events.
April 20, 2017 - Stanford Medicine Scope
Bio-X affiliate Justin Sonnenburg has been able to visualize multiple bacterial strains in lab mice’s gut by making them express unique combinations of fluorescent proteins.
April 19, 2017 - Stanford Medicine News Center
Umbilical cord blood from human newborns boosted old mice’s brain function and performance, shows research from Bio-X affiliates Tony Wyss-Coray and Martin Angst.
April 18, 2017 - Stanford Medicine News Center
Pretreatment with a stem-cell-activating protein significantly enhances healing in mice, Bio-X affiliate Thomas Rando says. The approach could eventually help people going into surgery or combat heal better from injuries they sustain.